Spending the cost of Bortezomib ACTe launch for the first injection of patients in need.

October 20, 2020

Author: Acteropharma

Considering the current situation in the country and taking into account the needs of patients, Actero Company decided to spend all the costs related to the unveiling of the drug Bortezomib ACTe on the first free injection of patients’ candidates receiving Bortezomib.

Therefore, by delivering the drug sample to physicians specializing in this field, treatment coverage began in a number of eligible patients.

Last News

Actero Men's Health Cup
January 18, 2025

Author:

Acteropharma
On the occasion of Movember and with the aim of raising awareness about men’s health, Actero organized a futsal tournament among pharmacies. This sports event, known as the “Men’s Health Cup,” saw widespread participation from various teams across the country and successfully highlighted the importance of men’s health issues.
hemato 2024
November 17, 2024

Author:

Acteropharma
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital, Tehran, alongside many experienced professors and colleagues from the Blood and Oncology Department.
Uro-Onco-2024
September 25, 2024

Author:

Acteropharma
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital